Suzhou Fushilai Pharmaceutical Co., Ltd. (SHE:301258)
China
· Delayed Price · Currency is CNY 33.35
-0.53 (-1.56%)
At close: Mar 9, 2026
SHE:301258 Market Cap
SHE:301258 has a market cap or net worth of 2.99 billion as of March 9, 2026. Its market cap has increased by 33.38% in one year.
Market Cap
2.99B
Enterprise Value
1.66B
Revenue
439.57M
Ranking
n/a
PE Ratio
39.67
Stock Price
33.35
Market Cap Chart
Since March 29, 2022, SHE:301258's market cap has decreased from 6.10B to 2.99B, a decrease of -50.95%. That is a compound annual growth rate of -16.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 2.99B | 2.62% |
| Dec 31, 2025 | 2.91B | 35.37% |
| Dec 31, 2024 | 2.15B | -27.24% |
| Dec 29, 2023 | 2.96B | -17.76% |
| Dec 30, 2022 | 3.60B | -41.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novoprotein Scientific | 2.94B |
| Shanghai Hile Bio-Technology | 3.17B |
| Landfar Bio-medicine | 2.91B |
| Jiangsu Sihuan Bioengineering | 2.89B |
| Cabio Biotech (Wuhan) | 3.25B |
| Shanghai Universal Biotech | 2.82B |
| Guangdong VTR Bio-Tech | 3.31B |
| Jilin Jian Yisheng Pharmaceutical | 2.78B |